The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cariban 10 mg/10 mg modified-release hard capsules

Italfarmaco S.p.A.PA1776/002/001

Main Information

Trade NameCariban 10 mg/10 mg modified-release hard capsules
Pyridoxine hydrochloride
Dosage FormModified-release capsule, hard
Licence HolderItalfarmaco S.p.A.
Licence NumberPA1776/002/001

Group Information

ATC CodeR06AA59 doxylamine, combinations


License statusAuthorised
Licence Issued15/05/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back